Skip to main content
    M

    MindWalk Holdings Corp. (HYFT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.93
    -0.06 (-5.83%)

    Market Cap: $47.10M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Earnings

    Upcoming Estimates

    Reports Dec 14, 2026 (est.)Period ending Oct 31, 2026
    EPS Consensus-0.06
    Range-0.08 - -0.05
    3 analysts
    EPS Revisions
    0
    3
    30d
    EPS Estimate DriftChange to current
    90d ago-0.04-48.7%
    60d ago-0.05-23.7%
    30d ago-0.05-23.7%
    7d ago-0.07+10.1%
    Current-0.06
    Revenue Consensus
    4.29M
    Range4.00M - 4.46M
    3 analysts
    Reports Mar 10, 2027 (est.)Period ending Jan 31, 2027
    EPS Consensus-0.07
    Range-0.07 - -0.07
    3 analysts
    EPS Revisions
    0
    3
    30d
    EPS Estimate DriftChange to current
    90d ago-0.05-45.9%
    60d ago-0.06-21.6%
    30d ago-0.06-21.6%
    7d ago-0.07-1.2%
    Current-0.07
    Revenue Consensus
    4.57M
    Range4.20M - 5.00M
    3 analysts
    Last 12 of 39 reported quarters and 3 upcoming estimates
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Apr 27EST
    Date TBD
    -N/AN/A-----
    Jan 27EST
    Exp. Mar 10
    --0.07-0.07 - -0.07--3
    0
    3
    30d
    -
    Oct 26EST
    Exp. Dec 14
    --0.06-0.08 - -0.05--3
    0
    3
    30d
    -
    Jul 26
    Reported Sep 14
    -0.09-0.05-0.06 - -0.05--3
    0
    1
    30d
    -
    Apr 26
    Reported Jul 22
    -0.06-0.05-0.06 - -0.05--3
    0
    1
    30d
    -
    Jan 26
    Reported Mar 12
    -0.06-0.04-0.04 - -0.04--1
    No revisions (30d)
    -
    Oct 25
    Reported Dec 15
    -0.05-0.01N/A--1
    0
    1
    30d
    -
    Jul 25
    Reported Sep 15
    -0.09-0.04N/A-----
    Apr 25
    Reported Jul 29
    -0.04-0.04N/A-----
    Jan 25
    Reported Mar 28
    -0.46-0.06N/A-----
    Oct 24
    Reported Dec 10
    -0.06-0.07N/A-----
    Jul 24
    Reported Sep 16
    -0.11N/AN/A-----
    Apr 24
    Reported Jul 29
    -0.10-0.08N/A-----
    Jan 24
    Reported Mar 14
    -0.08-0.07N/A-----
    Oct 23
    Reported Dec 14
    -0.07-0.10N/A-----

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF-4.79xFCF Yield-20.89%
    Profitability
    Profit Margin-105.20%Operating Margin-104.20%
    ROE-123.70%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio1.84xQuick Ratio1.75x
    Trading Statistics
    Beta0.78Avg Volume238.82K
    52-Week High$2.9952-Week Low$0.91

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 26.2% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 29.2, below 30, the oversold line.

    Moving Averages

    SMA 10$1.03
    SMA 20$1.11
    SMA 50$1.26
    SMA 200$1.34
    EMA 10$1.03
    EMA 20$1.10
    EMA 50$1.22
    EMA 200$1.36

    MACD

    Line: -0.09Signal: -0.08Hist: -0.01

    ADX

    ADX: 22.8+DI: 11.6-DI: 26.1

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down100.0
    PSAR$1.06

    Bollinger Bands

    Upper Band$1.30
    Lower Band$0.91
    %B Position3495%(Upper)
    Band Width0.05

    RSI (14-Day)

    Oversold
    29.2

    Momentum Oscillators

    Stoch %K14.1
    Stoch %D16.9
    Williams %R-93.8
    ROC (10d)-15.2%
    Momentum-0.17
    CCI (20d)-137.1
    MFI (14d)18.2

    Volatility Measures

    ATR (14d)$0.10(10.6%)
    StdDev (20d)0.10
    Hist Vol50.2%(High)

    Volume Flow

    VWAP$0.94
    OBV72.1M
    AD Line-41.0M
    CMF (20d)-0.300

    Volume Metrics

    Avg Vol (20d)243.9K
    Vol Ratio0.4x(Low)
    VWMA (20d)$1.08

    Pivot Points

    R3$1.21
    R2$1.14
    R1$1.06
    Pivot Point$0.99
    S1$0.91
    S2$0.84
    S3$0.77

    Advanced Oscillators

    TSI-30.68
    Ultimate Osc49.3
    KST-218.43

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about HYFT

    News

    HYFT Valuation

    GNG's valuation label for HYFT is Undervalued.

    P/FCF
    -4.8x
    P/B
    8.8x
    All HYFT metrics

    HYFT Profitability: Margins, ROIC and FCF

    MindWalk Holdings (HYFT) has a gross margin of 60.8%, an operating margin of -104.2% and a net margin of -105.2%.

    Gross margin
    60.8%
    Operating margin
    -104.2%
    Net margin
    -105.2%
    ROE
    -123.7%
    FCF yield
    -20.9%
    HYFT financial statements

    MindWalk Holdings Competitors

    Peers by sector and size for MindWalk Holdings (HYFT) include Rein Therapeutics, Talphera and Werewolf Therapeutics.

    Sector: Healthcare

    HYFT Analyst Ratings

    MindWalk Holdings (HYFT) has a Buy consensus from 3 analysts: 3 Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell.

    Consensus
    Buy
    Analysts
    3
    Strong Buy
    0
    Buy
    3
    Hold
    0
    Sell
    0
    Strong Sell
    0

    HYFT Bull Case vs Bear Case

    Bull case

    • HYFT grew quarterly revenue 21.3% year over year.

    Bear case

    • HYFT has a -105.2% net profit margin.

    HYFT Earnings: Next Report

    The next report from MindWalk Holdings (HYFT) is expected on Dec 14, 2026.

    Estimate revisions (30 days, fiscal period ending Oct 31, 2026)
    0 up, 3 down

    HYFT Earnings Date

    HYFT reports Dec 14, 2026. The date is estimated.

    HYFT Earnings Call

    The latest HYFT earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Updated Sep 16, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About HYFT

    When does HYFT report earnings?

    MindWalk Holdings Corp. (HYFT) is expected to report earnings on Dec 14, 2026.

    Does HYFT pay dividends?

    MindWalk Holdings Corp. (HYFT) does not currently pay a regular dividend.

    What is HYFT's market cap?

    MindWalk Holdings Corp. (HYFT) has a market capitalization of $47.10M with a current stock price of $0.93.

    How do analysts rate HYFT stock?

    3 analysts cover MindWalk Holdings Corp. (HYFT): 0 rate it Strong Buy, 3 Buy, 0 Hold, 0 Sell and 0 Strong Sell, a consensus of Buy.

    HYFT pages: Overview, Financials

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.